about
Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trialLow-dose oral imatinib in the treatment of systemic sclerosis interstitial lung disease unresponsive to cyclophosphamide: a phase II pilot study.Pain in primary Sjögren's syndrome.Emerging concepts on inhibitors of indoleamine 2,3-dioxygenase in rheumatic diseases.From mechanisms of action to therapeutic application: A review on current therapeutic approaches and future directions in systemic sclerosis.Comparison between iloprost and alprostadil in the treatment of Raynaud's phenomenon.Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis.Does ex vivo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation in systemic sclerosis patients?Regional implantation of autologous adipose tissue-derived cells induces a prompt healing of long-lasting indolent digital ulcers in patients with systemic sclerosis.Autologous fat grafting in the treatment of fibrotic perioral changes in patients with systemic sclerosis.Anti-endothelial cell antibodies and autoimmune diseases.Antibodies to endothelial cells identify myocardial damage and predict development of coronary artery disease in patients with transplanted hearts.Characterization of murine monoclonal anti-endothelial cell antibodies (AECA) produced by idiotypic manipulation with human AECA.Antibodies to endothelial cells in primary vasculitides mediate in vitro endothelial cytotoxicity in the presence of normal peripheral blood mononuclear cells.Corneal involvement in rheumatoid arthritis: an in vivo confocal study.Inflammation in dry eye associated with rheumatoid arthritis: cytokine and in vivo confocal microscopy study.Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database.Immunosuppressive activity of 15-deoxyspergualin on normal and autoimmune peripheral blood mononuclear cells.Leflunomide-induced subacute cutaneous lupus erythematosus with erythema multiforme-like lesions.Recombinant human erythropoietin stimulates vasculogenesis and wound healing in a patient with systemic sclerosis complicated by severe skin ulcers.Serologic profile and mortality rates of scleroderma renal crisis in Italy.Anti-endothelial cell IgG antibodies from patients with Wegener's granulomatosis bind to human endothelial cells in vitro and induce adhesion molecule expression and cytokine secretionPulmonary arterial hypertension in primary myelofibrosis is common and associated with an altered angiogenic statusActivation of the immune system and coronary artery disease: the role of anti-endothelial cell antibodiesRituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: a clinical observational studyIncreased levels of circulating endothelial cells in chronic periaortitis as a marker of active diseaseA Die-Hard Giant CapillaryReply to J. Magalon et alAntiendothelial Cell Antibodies Induce Apoptosis of Bone Marrow Endothelial Progenitors in Systemic SclerosisSjögren's syndrome disease damage index and disease activity index: Scoring systems for the assessment of disease damage and disease activity in Sjögren's syndrome, derived from an analysis of a cohort of Italian patientsBone marrow endothelial progenitors are defective in systemic sclerosisPrecocious intima-media thickening in patients with primary Sjögren's syndromeCirculating endothelial cells as a marker of ongoing vascular disease in systemic sclerosisAutoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosisAntibody to carbonic anhydrase II is present in primary biliary cirrhosis (PBC) irrespective of antimitochondrial antibody statusEndothelial cells as target for antiphospholipid antibodies. Human Polyclonal and Monoclonal Anti-β2-Glycoprotein I Antibodies React In Vitro with Endothelial Cells Through Adherent β2-Glycoprotein I and Induce Endothelial ActivationAntiphospholipid Antibodies and Endothelial CellsCharacterization of the Endothelial Surface Proteins Recognized by Anti-Endothelial Antibodies in Primary and Secondary Autoimmune VasculitisIn vitro and ex vivo effect of tiaprofenic acid on human peripheral blood mononuclear cellsThrombotic events in patients with systemic sclerosis treated with iloprost
P50
Q19862843-93288D7E-AD0B-4003-8139-6B7C1F1491D4Q34486262-143A98B0-F835-4C67-9638-5A75317098B2Q34672235-CBD67F9C-14BE-42FD-A674-ED0F8107457DQ38042154-440C7BD5-EAE1-4F57-B981-B6D058BCD009Q38815653-3B4F09BE-8E98-498A-A704-EB3E1335A53EQ39694879-DB566297-54F8-4B79-AC50-7373263D614CQ39877290-6E75EC51-0586-40CA-B54B-7B3714F25640Q40237552-9FA41EE6-B23E-47AD-8BCB-6921CB2A8839Q40243726-7BAA2CD5-D17C-4794-8C3B-110E318FBF47Q40251130-CB706DE6-EEAC-45B7-A1DA-5862915A6F94Q40559205-FE0FCD1B-32CF-42E5-B658-8DD028EA6D6CQ40793332-CB07E54F-6A4B-4AE9-8FD7-6412C7A8BA5CQ41017198-9D4206D4-800B-4ACB-8E63-FEEC189FD3ABQ41126709-BB98B0A0-E6B7-48C2-9334-C255977F719CQ42524196-71EE003D-C918-4204-A8EC-B4151D9697ABQ43539087-1E9DA499-CEDB-48BD-A8EC-E9479134CCD5Q43730907-7ABD891F-1DBC-403C-8AF1-47A880E29F41Q44311271-2B3742E4-72FF-4DF9-A996-399279D7EFB5Q46643919-4CD51953-836E-482A-8E45-D8FD2F68B08BQ46651423-8E8EEBC7-93CF-4147-BC63-783E907AB527Q47677729-2193FB7B-748B-4E23-AF55-CE24427C6A83Q56943448-0CF71ED9-6BA1-4FD1-85B6-09C67DAE0D3DQ57488209-3DAD3EC3-E586-4E64-9AB7-84B97FA915F2Q60678824-FDEC03A3-AFEE-4CC2-85A9-46C5EB235976Q60729384-750FFCA4-CBC5-4AC7-B393-B82BDEC91AA2Q60729419-3087B996-17E7-4F73-8E50-272A0751A061Q62395135-B6A67CCC-D96B-479A-9538-96D8CEB61888Q62395139-76D8EFEB-482E-48B3-A207-CD02C27D35F3Q62395140-587764B6-3F82-4F51-BE68-072C1842BB9FQ62395161-378909EA-1F14-47AF-A0EE-F4CDC1AFB483Q62395162-613B8855-A258-463D-A3AA-AE2D02BA84FDQ62395171-166C8E85-EE6C-410D-A24B-99294DD00304Q62395188-C4159A31-D32D-4677-911A-927E76DA7132Q62395191-54ADD93C-95C5-450C-B396-3DCC29E0C98FQ62395194-F71F8672-4E2F-4BFB-8089-027C81A89B88Q62395215-017A77D3-E2EF-4836-A308-E515E302C539Q62395221-6D0249BA-6534-4507-A15B-BA601FD37069Q62395238-3C0CF585-D02C-44C0-A972-F909258D0330Q62395243-DD65AC98-4A8A-4F99-A654-82D101FFDFF3Q74324069-8B975D0D-B59E-4F8A-B716-7730C9D5EC1E
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Nicoletta Del Papa
@ast
Nicoletta Del Papa
@en
Nicoletta Del Papa
@es
Nicoletta Del Papa
@nl
Nicoletta Del Papa
@sl
type
label
Nicoletta Del Papa
@ast
Nicoletta Del Papa
@en
Nicoletta Del Papa
@es
Nicoletta Del Papa
@nl
Nicoletta Del Papa
@sl
altLabel
Nico
@en
prefLabel
Nicoletta Del Papa
@ast
Nicoletta Del Papa
@en
Nicoletta Del Papa
@es
Nicoletta Del Papa
@nl
Nicoletta Del Papa
@sl
P1053
K-8513-2016
P106
P1153
7004010710
P21
P31
P3829
P496
0000-0003-1549-8852